Keyphrases
COVID-19
100%
Hospitalized Patients
66%
Dipeptidyl Peptidase 1
50%
Brensocatib
50%
Clinical Practice
50%
Randomized Placebo-controlled Trial
50%
Patients with COVID-19
37%
COVID-19 Pandemic
37%
Patients with Cardiovascular Diseases
25%
Record Linkage
25%
Medicine Use
25%
Neutrophils
25%
Placebo-controlled Trial
25%
Metformin
25%
Chronic Heart Disease
25%
Observational Evidence
25%
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
25%
Neutrophilic Inflammation
25%
SFX-01
25%
Sustainable Medicines
25%
Population-based
25%
Aortic Stenosis
25%
Heart Failure
25%
Clinical Scenarios
25%
Renin-angiotensin System
25%
Informatics Research
25%
Electronic Health Records
25%
Patients with Diabetes
25%
Antihyperglycemic
25%
Proteome
25%
Clinical Practice Guidelines
25%
Acute Changes
25%
Prescribing Practices
25%
Stewardship
25%
Beta-blockers
25%
Clinical Applicability
25%
Health Informatics
25%
Sustained Change
25%
Community-acquired Pneumonia
25%
Adaptive Platform Trial
25%
Clinical Trial Design
25%
Platform Trials
25%
Clinical Research
25%
Severe Disease
22%
Healthcare
20%
Clinical Status
20%
SARS-CoV-2 Infection
18%
Placebo
17%
Neutrophil Elastase
17%
National Health Service
16%
Medicine and Dentistry
COVID-19
100%
Placebo
75%
Dipeptidyl Peptidase
50%
Infection
25%
Aortic Stenosis
25%
Electronic Health Record
25%
Decision Making
25%
Community-Acquired Pneumonia
25%
Population Health
25%
Heart Disease
25%
Patient with Diabetes
25%
Gene Linkage
25%
Observational Study
25%
Glycon
25%
Cardiovascular Disease
25%
Health Informatics
25%
Medicine
25%
Congestive Heart Failure
25%
Clinical Trial Design
25%
Diseases
17%
National Health Service
16%
Serine Proteinase
15%
Severe Acute Respiratory Syndrome Coronavirus 2
14%
Neutrophil
13%
Transcription Factor Nrf2
12%
Sulforaphane
12%
Combination Therapy
12%
Clinical Research
12%
Physical Examination
8%
Health Care
8%
Oxygen Saturation
8%
Public Health
8%
Health System
8%
Lymphocyte
8%
Serositis
6%
Antioxidant
6%
Blood Pressure
6%
Anti-Inflammatory Drug
6%
Oncology
6%
Baricitinib
6%
Dexamethasone
6%
Arm
6%
Pathogen
6%
Patient Population
6%
Respiratory Medicine
6%
Antibody Therapy
6%
Infectious Disease
6%
Adverse Event
5%
Intention-to-Treat Analysis
5%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
75%
Dipeptidyl Peptidase
50%
Pandemic
37%
Diseases
35%
Inflammation
29%
Infection
25%
Observational Study
25%
Metformin
25%
Heart Disease
25%
Community Acquired Pneumonia
25%
Aortic Stenosis
25%
Congestive Heart Failure
25%
Cardiovascular Disease
25%
Clinical Research
25%
Clinical Trial Design
25%
Combination Therapy
25%
Serine Proteinase
15%
SARS Coronavirus
14%
Sulforaphane
12%
Transcription Factor Nrf2
12%
Baricitinib
12%
Dexamethasone
12%
Infectious Agent
12%
Anti-Inflammatory Drug
6%
Antioxidant
6%
Adverse Event
5%